Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Solid Tumor Testing Market Size?
In recent times, the market size of solid tumor testing has seen considerable expansion. It is projected to increase from $27.96 billion in 2024 to $29.94 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.1%. Factors contributing to this growth during the historic period can be associated with precision medicine, ineffective tumor-specific drug delivery, suboptimal therapeutic efficacy, high costs, and reductionist methods applied to cancer chemotherapies.
The market size for solid tumor testing is projected to experience significant expansion in the upcoming years, expected to rise to $39.95 billion by 2029, with a compounded annual growth rate (CAGR) of 7.5%. This projected growth during the forecast period can be linked to the rising prevalence of cancer, enhancement in healthcare infrastructure, the advent of AI and IoT-based diagnostic tools, and escalated government initiatives. The forecast period also forecasts breakthroughs in diagnostic tools, the launch of nanocarrier-based treatment, strategic collaborations, and next-generation testing equipment.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12658&type=smp
Which Factors Are Steering Growth In The Solid Tumor Testing Market?
The solid tumor testing market is predicted to grow due to the increasing prevalence of cancer. The malady of cancer characterizes the uncontrolled growth and spread of rogue cells in our bodies. These rogue cells, often referred to as cancer cells, have the tendency to invade neighboring tissues and organs. In certain instances, they can even spread to other regions of the body via the bloodstream or the lymphatic system. About 90% of adult cancers are solid tumors. Solid tumor testing aids in the detection of these cancerous cells in a patient’s blood, even if the cancer is not noticeably present on any imaging test. For example, a report published by the Centers for Disease Control and Prevention (a national public health agency based in the US), in June 2023 showed that there were 1,603,844 new cases of cancer and 602,347 cancer-related deaths in the US in 2020. In addition, for every 100,000 people, there were 403 new cases of cancer and 144 cancer-related deaths. Thus, the increasing incidence of cancer is fueling the expansion of the solid tumor testing market.
How Is The Solid Tumor Testing Market Organized By Different Segments?
The solid tumor testingmarket covered in this report is segmented –
1) By Type: Genetic Testing; Conventional Testing
2) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Cervical Cancer
3) By Application: Clinical; Research
4) By End-Users: Hospitals; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic Research Institutions
Subsegments:
1) By Genetic Testing: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescence In Situ Hybridization (FISH)
2) By Conventional Testing: Histopathology; Cytology; Imaging Techniques
What Current And Upcoming Trends Are Shaping The Solid Tumor Testing Market?
The emergence of advanced liquid biopsy test solutions is a significant trend in the solid tumor testing market. Prominent firms in the market are concentrating on creating these cutting-edge liquid biopsy tests to consolidate their market stance and gain a competitive edge. Take, for example, NeoGenomics Inc., a leading laboratory company from the US. In June 2020, they rolled out a comprehensive collection of three liquid biopsy tests for solid tumors for cancer patients. These pioneering tests have the ability to identify cancer cells in the blood of patients with solid tumors, even when the cancer is not detected via imaging tests. These tests can guide doctors on any further testing or treatment required. Moreover, these tests are non-invasive, facilitate early detection, can be tailored for individual treatment, and have FDA approval. They feature a turnaround time of seven days or less, which can greatly reduce the time physicians spend waiting for results.
Who Are The Most Influential Companies In The Solid Tumor Testing Market?
Major companies operating in the solid tumor testing market include Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company (BD), Quest Diagnostics Incorporated, Tosoh Corporation, Agilent Technologies Inc., bioMerieux Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Miltenyi Biotec GmbH, Natera Inc., Myriad Genetics Inc., Novocure Inc., Invitae Corporation, Guardant Health Inc., Foundation Medicine Inc., Epic Sciences Inc., Biocare Medical LLC, Agena Bioscience Inc., Caris Life Sciences Inc., 20/20 Gene Systems Inc., Grail Inc., Avant Diagnostics Inc., Genomic Testing Cooperative, Eutropics Pharmaceuticals Inc., Anixa Biosciences Inc., Cellular Biomedicine Group.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report
Which Region Dominates The Solid Tumor Testing Market Today?
North America was the largest region in the solid tumor testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12658&type=smp
Browse Through More Reports Similar to the Global Solid Tumor Testing Market 2025, By The Business Research Company
Tumor Ablation Therapy Devices Global Market Report 2025
Tumor Embolization Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Testing Software Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/testing-software-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model